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Polypharmacy is increasing and managing large number of medicines may create a burden for 
patients. Many patients have negative views of medicines and their use can adversely affect quality of 
life. No studies have specifically explored the impact of general long-term medicines use on quality of 
life. 
Objective 
To determine the issues which patients taking long-term medicines consider affect their day-to-day 
lives, including quality of life. 
Setting 
Four primary care general practices in North West England 
Methods 
Face-to-face interviews with adults living at home, prescribed four or more regular medicines for at 
least one year. Interviewees were identified from primary care medical records and purposively 
selected to ensure different types of medicines use. Interviews were recorded, transcribed and 
analysed thematically. 
Results 
Twenty-one interviews were conducted and analysed. Patients used an average of 7.8 medicines, 51% 
were preventive, 40% for symptom relief and 9% treatment. Eight themes emerged: relationships with 
health professionals, practicalities, information, efficacy, side effects, attitudes, impact and control. 
Ability to discuss medicines with health professionals varied and many views were coloured by 
negative experiences, mainly with doctors. All interviewees had developed routines for using multiple 
medicines, some requiring considerable effort. Few felt able to exert control over medicines routines 
specified by health professionals. Over half sought additional information about medicines whereas 
others avoided this, trusting in doctors to guide their medicines use. Patients recognised their inability 
to assess efficacy for many medicines, notably those used for prophylaxis. All were concerned about 
possible side effects and some had poor experiences of discussing concerns with doctors. Medicines 
led to restrictions on social activities and personal life to the extent that, for some, life can revolve 
around medicines. 
Conclusion 
There is a multiplicity and complexity of issues surrounding medicines use, which impact on day-to-
day lives for patients with long-term conditions. While most patients adapt to long-term medicines 





 Many aspects of long-term medicines use can potentially affect patients’ quality of life, in 
addition to the conditions for which they are prescribed, and this impact needs to be more 
widely recognised.  
 Health professionals should consider the potential burden of medicines use on any individual 
when managing long-term conditions.  
 A means of quantifying the medicines-related issues which potentially affect patients’ quality 
of life may prove useful. 
  
Introduction 
An increasing body of literature recognises that while clinical guidelines and specialist care may 
result in better disease management, they also create a drive towards prescribing leading to multiple 
medicines use which is becoming burdensome to patients[1,2]. Increasing medicines use leads to 
more frequent problems with medicines[3]. Polypharmacy in the elderly can increase cognitive 
dysfunction through anticholinergic burden[4,5] with adverse effects on social functioning and mood. 
Many prescribed medicines are used to prolong life or prevent secondary events; in England 14 of the 
top 20 dispensed drugs in 2010 fell into this category, accounting for 26% of all items dispensed[6]. 
Patients are expected to take these medicines long-term, with many providing no direct positive 
feedback in terms of efficacy, but potentially causing adverse effects. Adverse effects are only one 
aspect of medicine use which could cause difficulties, distress or place a burden on patients. Therefore 
we suggest that long-term medicines use could potentially adversely affect quality of life and suggest 
defining this as a modification of Bowling’s definition of health-related quality of life: “individual 
responses to the physical, mental, and social effects of medicines use on daily living that influence the 
extent to which personal satisfaction with life circumstances can be achieved[7].” 
 
Although there is increasing emphasis on patient-reported outcomes, studies rarely incorporate patient 
views of using medicines. A systematic review showed many patients hold negative views towards 
medicines, with some resisting taking medicines because of concerns about harm or dependence[8], 
but positive views also exist [9]. One patient-led study declared that “many older people’s lives are 
governed by the drug regimes they must follow, they experience varying degrees of difficulty in 
complying and their quality of life suffers as a result” [10]. Purposeful non-adherence, through 
adaptation of medicine regimens to personal lifestyle by occasional missed doses, reducing doses or 
frequency of medicines to minimise adverse effects may benefit some patients[11].  
 
Most qualitative studies exploring the impact of using medicines have involved one group of 
medicines or patients[8]. Quantitative studies measuring impact have focused on specific aspects of 
medicines use, such as anticholinergic burden[12], capacity to manage medicines[13] and satisfaction 
with medicines[14]. We identified no qualitative studies specifically assessing the impact of using 
long-term medicines on day-to-day life. 
 
This study therefore aimed to explore patients’ views of using long-term medicines on their day-to-
day lives, to facilitate developing a tool to measure the impact and burden of using medicines, which 
could affect quality of life.  
 
Objective  
To determine the medicine-related issues which patients taking long-term medicines consider affect 
their day-to-day lives. 
 
Method 
A series of face-to-face semi-structured interviews were undertaken with adult patients regularly 
prescribed four or medicines. Approval was obtained from both NHS (Ref: 08/H1016/71) and 
University Research Ethics Committees and Sefton Primary Care Trust (PCT). 
 
Setting and inclusion criteria 
Participants were recruited from four general medical practices in North West England covering 
varying levels of deprivation. Inclusion criteria were: adults, living at home taking at least four 
medicines for chronic medical conditions for at least one year. Exclusion criteria were: patients under 
18 years of age, physical, mental or cognitive impairment reducing ability to be interviewed, any 
patient whom their GP felt was unsuitable due to current physical, mental or personal circumstances.  
 
Recruitment 
Practice-based pharmacists identified patients fulfilling inclusion criteria from medical records. After 
stratification by age and sex, a random sample were invited to participate by letter, with an 
information leaflet and eligibility form, requesting contact details and prescribed medicines currently 
used, plus freepost envelope. Medicines details were used to purposively sample thirty potential 
participants from among those agreeing to interview, to maximise variation in medicines and 
formulations.  
Interviews 
The interview guide (Box 1), developed by the research team utilising medicine-related problems 
from the literature and professional expertise, was piloted with three individuals using long-term 
medicines. This assessed the guide’s ability to enable and encourage respondents to explore the issues 
they felt were relevant to using medicines, particularly those potentially reducing or enhancing the 
quality of their day-to-day lives, while allowing views to be raised on topics not covered. 
<<INSERT BOX 1>> 
Semi-structured interviews lasting approximately 45 minutes were conducted by a psychologist, 
audio-recorded with permission and transcribed. Thematic analysis was carried out using an inductive 
approach[15]; themes were identified separately and agreed by two researchers, then both analysed 
and coded all transcripts independently.  Interviews continued until data saturation was reached. 
 
Results and Discussion 
A total of 131 patients agreed to participate in the study, with 105 agreeing to interview. Of the 30 
invited for interview, 22 agreed. Saturation of themes was reached after analysis of 21 interviews. To 
confirm this, a further interview was conducted and analysed but no further issues emerged. The 
remaining respondents and those not agreeing to interview were invited to participate in later stages of 
the study[16]. The 21 interviewees comprised 11 males and 10 females, age range approximately 20 
to over 80, using 163 prescribed medicines, range 4 to 17, average 7.8 per patient. Medicines used 
were categorised using the British National Formulary[17] and formulation ( Table 1). 
  
Table 1 Medicines used by the 21 interviewees 
 
Therapeutic category of medicines*  Number of medicines 
Gastro-intestinal system 20 
Cardio-vascular system 53 
Respiratory system 11 
Central nervous system 17 
Endocrine system 16 
Obstetrics, gynaecology and urinary tract disorders 5 
Nutrition and blood 16 
Musculo-skeletal and joint problems 11 
Drugs acting on the eye 4 
Drugs acting on the skin 10 
Formulations Number of medicines 
Oral solid dose 126 (including one chewable tablet) 
Oral liquid 6 
Inhalers 7 
Eye drops 4 
Topical skin 10 
Suppositories 3 
Injection 5 
Sublingual spray 2 
Primary purpose   
Symptomatic relief 65 (39.9%) 
Prophylaxis 84 (51.5%) 
Treatment 14 (8.6%) 
 
* categorised by BNF chapter 
 
 
Eight major themes emerged from the interviews: relationships with health professionals, 
practicalities, information, efficacy, side effects, attitudes, impact and control.  
 
1. Relationships with health professionals 
Although not included in the interview guide, all patients raised this issue, indicating an inextricable 
perceived link between medicines and relationships with those who prescribe and provide them. 
These relationships are fundamental to how many patients perceive and use medicines, impacting on 
other aspects, as described later. Perceptions concerning health professionals’ attitudes towards 
participants and their medicines differed dramatically. Five accepted decisions, placing unquestioning 
trust in doctors, while expressing a feeling of powerlessness in the relationships[8], but two felt a need 
to question or challenge recommendations. 
“I just take what the doctor said and I believe them, they’ve got tremendous power, doctors haven’t 
they?” (2)   
 
“I know when it’s not working and when it’s not working I will actually go into me doctor and say 
‘look this is not working, can we up the dosage or can we try this can we try that.’ ” (7) 
 
Eight participants described negative experiences and dissatisfaction with these relationships, citing 
some unacceptable aspects of consultation style, including not listening to legitimate views.  
 
“sometimes you feel as if you’re getting fobbed off… [with] medications which you last tried ten years 
ago which didn’t work ten years ago why are they going to work now? And you think well, this is just, 
‘I’ve given you something, go away and come back in six months’.” (5) 
Few felt able to discuss concerns about medicines with health professionals; one described 
deliberately selecting an approachable individual.  Five raised barriers such as lack of time, language 
and lack of experience. 
“Consultants have a language of their own and I think you need an interpreter most of the time to 
understand precisely what they’re saying.” (3) 
 
Many studies have explored the doctor-patient relationship and the impact of communication styles on 
patient satisfaction, adherence to therapy, understanding and health outcomes[18-20]. Our findings 
suggest that despite teaching and guidance about the need to adapt consultation skills to individual 
patients’ needs and increased patient involvement in decision-making[11], some patients are still 
justifiably dissatisfied.  
Four patients expressed dissatisfaction about lack of continuity of care and failure to transfer 
information about medicines. 
 
 “he said ‘oh carry on putting the drops in’ then I saw the student who said ‘carry on putting the drops 
in’, so two people had said without picking up that I was allergic to it.” (6) 
 
Continuity of care incorporates three aspects: informational, management and relationship 
continuity[21], and may be positively associated with patient satisfaction[22,23]. Its lack is associated 
with higher morbidity[24], while failure to share or transfer information about medicines leads to both 
polypharmacy and other problems, such as the potential for adverse effects illustrated here, with its 
attendant impact on quality of life[25]. 
 
Ten interviewees discussed pharmacists and their staff, most positively, citing helpfulness in supply 
and ability to explain about medicines, although one felt pharmacies’ busyness made them unsuitable 
places to discuss medicines. Busyness has previously been identified as a barrier to uptake of 
pharmacy services[26,27]. 
   
 “I don’t really like dealing with the pharmacy because when you go over there, there’s loads of people 
in there… but I don’t mind dealing with the doctors.” (8)   
  
These positive experiences may derive from the view that pharmacists are ‘experts on medicines’ and 
more easily approached than doctors, as no appointment is needed[28,29].  
 
2. Practicalities of using medicines 
Interviewees who used them praised prescription collection and delivery services. Nine interviewees 
however were unhappy with the effort required to obtain both prescriptions from surgeries and 
medicines from pharmacies, including failure to synchronise repeat quantities requiring unnecessarily 
frequent prescriptions, insufficient medicines supplies and concern about running out. 
 
 “when I get to the end of my prescription I worry in case I don’t get my prescription in so that I don’t 
run out. I mean I really would worry, you know.” (6) 
 
Although all participants had developed routines for using medicines, which had become automatic or 
‘second nature’ – “you think nothing of it”-  interviews revealed the extent of the physical and 
organisational effort required by some patients in using medicines. This was particularly evident for 
complex routines, such as varying daily doses or once weekly dosing, and when medicines changed. 
The impact of changes in daily routine sometimes resulted in medicines not being used.  
 
”I don’t like these (compliance aid] because sometimes my fingers don’t lift the thing up… I don’t have 
long nails you see…The number of times I’ve dropped one in the bathroom, been hunting all over.” (2) 
.”.. two one day, three the next, I write myself a little card, Monday, Tues…I take the back of the pack 
and I put September one, two, three, right down to fifteen, then I start another page, sixteen and so on.  
And then I do another one for October so just in case I throw that box away.  Otherwise I wouldn’t 
remember how many I’d had the day before if I didn’t write it down.” (2) 
 
Practical problems such as difficulties in opening packaging, identifying medicines due to 
manufacturer changes and the need to develop strategies for remembering to take medicines, are 
common[9,30]. Several studies demonstrate that regime complexity is in itself problematic[8]. One 
study found on average five issues with potential to impact adversely on medicines taking among 
older people[31]. A variety of services enabling pharmacists to support medicines use exist in many 
countries[32-35]. These services should consider the patient’s experience of using medicines[11], but 
in reality often expound the predominant beliefs about medicines’ benefits, essentially attempting to 
increase adherence rather than question medicines’ impact or reduce burden. 
 
3. Information about medicines 
More than half the participants felt they needed information to allay their concerns, beyond that 
provided directly by health professionals, which they obtained by various means, including books, 
patient information leaflets (PILs) and the internet.  
“I’d like to know what I’m taking them for and what it does and what if I don’t take them and what 
happens and long-time problems that can occur taking them. You know, cause you’re forever hearing 
them on tele aren’t you” (4) 
 “If I don’t know, I’ll buy a book, then I’ll read up on it” (18) 
Conversely, four participants either did not want to know about their medicines or would never seek 
further information. One was uncertain about the usefulness of PILs and three considered that 
information caused or worsened rather than allayed concerns, meaning further reassurance and 
clarification from a health professional was needed.  
 “some people read this (leaflet) and think ‘my God I could have that, could have this’ … So I’m 
conscious of that, you know, and I have asked at length, exactly what’s in this…plus exactly what does 
it do?” (20)  
  
Much research suggests that most patients want information about their prescribed medicines 
[8,11,30]. Several studies suggest that while most patients read  PILs, particularly the section on side 
effects, health professionals often fail to recognise or respond to this desire[10,36,37], with the 
potential for patients to become dissatisfied. GPs’ perceptions about what information patients want is 
a major influencing factor on consultation behaviour[38], with potential to influence relationships.  
 
4. Efficacy 
For many medicines, interviewees were clear about perceived efficacy, but also recognised that 
prophylactic medicines provided no tangible evidence of benefit.  
 
 “If it was a pain killer you can assess it…there’s no visible signs (with antihypertensives)” (15)  
With medicines prescribed for symptomatic relief, as opposed to specific treatment or presumptive 
diagnosis, efficacy is detectable and patients can assess it by reducing or stopping them and observing 
symptoms[8,39].  
“I know the alternative would be hell because I’ve tried without them” (1) 
The overall proportion of symptomatic medicines such as analgesics in overall prescribing is 
decreasing, while prophylactic medicines are increasing[7]. Over 50% of all medicines being used by 
the interviewees were essentially prophylactic, with only approximately 40% potentially providing 
some positive feedback by way of symptom relief (Table 1). 
 
Three patients believed that medicines may counteract each other when taken together, so deliberately 
spaced doses throughout the day. Another’s trust in their prescriber extended to the assumption that 
co-prescribed medicines were unlikely to interact. For one patient, medicines’ efficacy was judged to 
be related to the haste with which they were prescribed. 
 
“So the medicine didn’t help me and it did really affect my quality of life taking those, because of the 
way I was feeling.  And I thought you know … sometimes they try and put you on tablets too quickly.  
You don’t get that discussion time to say ‘well can we discuss the side effects of these tablets?’ ” (9)  
 
The view that doctors prescribe medicines too quickly has been found to result from perceptions of 
patient’s desire for a prescription during consultation[40,41]. This contrasts with actual patient views 
showing a general aversion to using medicines and some resistance to doing so[8]. 
 
5. Adverse effects 
Three participants accepted that side effects were inevitable and were prepared to tolerate them to 
obtain benefits from medicines. Three others had discontinued some medicines, viewing the side 
effects as unjustifiable, worse than the problem the medicine was treating. Other studies have shown 
similar views, concerning medicines for HIV, schizophrenia and rheumatoid arthritis[8]. 
 
“I curse them and they’ve made me so uncomfortable, all the side effects.” (15) 
 
In addition to actual experiences of side effects, one participant imagined experiencing all those listed 
in the PIL, while another expressed concern about when side effects would occur, both in the 
immediate and longer term.  
 
“I think if you had those side effects, your quality of life would be very affected.  And I mean by that it’s 
not just having stomach upsets, it’s actually the anxiety (of) when are they going to hit me?” (9)   
 
Two participants found difficulty in discussing potential side effects with health professionals. 
 
“I mean when I mentioned it at the hospital it was like brushed off if I’m honest. It wasn’t like…it might 
be you know a side effect, all medications have side effects, yeah it’s understandable, do you want to sit 
down and talk and we’ll identify which medication is causing the problems.” (9) 
 
Doctor dismissal of patients’ perspectives on adverse effects has been found previously[40,42,43], 
although many patients can identify adverse effects[44]. Adverse effects are relatively 
common[36,45,46], can seriously affect quality of life, reduce willingness to use medicines[9,11] and 
have the potential, if not identified, to result in yet further prescribing to alleviate them, the 
‘prescribing cascade’[47]. 
 
6. Attitudes towards medicines 
Six participants felt that medicines were necessary to relieve symptoms or prolong life and were 
grateful for these benefits, while at the same time wishing they did not need medicines.  
 
“they definitely do (disrupt your life) because one thing you do know is you’ll never have a normal day 
again, you know when you get up and you don’t have to think about taking medicines or doing the 
injections… I’m getting fed up with taking these now. I wish I could just throw them all in the bin.” (9) 
 
Seven however showed more negative attitudes,  using words such as ‘hate’ or ‘curse’ them; one was 
‘embarrassed’ by taking medicines to the extent that she would ‘rather put up with the problem than 
take the medicine’, while one showed the potential of such an attitude on future medicines use. 
“I don’t like taking them. If it’s another one they’re going to give me, I’m pretty reluctant then to have 
any more” (14) 
 
Acceptance of medicines is associated with acceptance of illness, shown in various conditions, 
including asthma, HIV, schizophrenia and cancer[8]. Such acceptance varies between individuals and 
within individuals depending on the particular medicine[8,9]. Whether or not a patient views a 
medicine as positive can be influenced by worries about possible adverse effects, dependence and 
long term harm[8,41], all of which were voiced by participants. In particular three expressed concerns 
about long-term medicines use, both in terms of their potential for dependency and the need to accept 
theoretical long-term benefits of prophylaxis against future problems.  
“are they doing anything for me? they must be doing something good but I don’t know. I’m 
still transfixed over the situation of not having any symptoms, maybe they’re keeping the 
symptoms at bay.” (14) 
 
Concerns about dependence and tolerance may lead to regime changes, including ‘drug holidays’[8].  
 
7. Impact of taking medicines on everyday life 
Six participants described disruptive effects of medicines on both routine everyday activities, such as 
meal times, going to bed and sex life, and non-routine activities such as holidays or outings, beyond 
any impact of medical conditions.  
 “I’ve been dragged out of a few pubs before today, you know, because I’ve been in the toilets 
with me needle and the bouncers have been to the door and dragged me out thinking I’m 
injecting heroin or something and you don’t even get to explain ‘I’m a diabetic.’ ” (4) 
Adverse impacts on social activities has been shown previously involving friendships, relationships 
and work, while the perceived need to take medicines exactly as prescribed can also interrupt daily 
life[8,30]. Our participants suggested that having to take medicines routinely could in itself be 
disruptive. While most perceived this as manageable, it required a good knowledge of medicines’ 
indications, how they worked and how changes in routine affected efficacy. Not all adaptations to 
accommodate medicines use were based on sound knowledge, leading to potentially unnecessary 
changes in routine or avoidance of activities. For example, in the following quotation, lifestyle 
disruption occurred to accommodate the perceived importance of administration time. 
“if I’m going out in the evening… I can … take the more vital ones earlier on in the day so they get into 
my system… sometimes it may mean that I have to stay up a little while longer than I would normally 
do to take things like statins or the ACE inhibitors you know, because they tend to have to be taken late 
at night” (3) 
 
Health professionals, often guided by manufacturers’ recommendations, frequently emphasise the 
importance of regular and continuous medicine use, including specific advice about timing. The 
evidence for such emphasis is variable and the impact of occasional small variations in timing on 
efficacy probably minimal, but could be significant for patients’ quality of life.  
8. Control over using medicines. 
Most participants felt they had control over some of their medicines in terms of timing, doses and 
whether to use them at all. Indeed, one patient had stopped all his cardiovascular prophylactic 
medicines against advice because of adverse effects he considered unacceptable. 
 ‘I think that, the way I feel has been improved. I may not live any longer but it’s just, I feel better.” 
(13) 
  “to a large extent that particular drug I’m in charge of… take them as I want, nothing to do with the 
doctor.” (17) 
 
One was convinced of differences in both side effects and efficacy between branded and generic 
products, but had little control over the choice of product.  
“they say these days that there is no difference between specific and generic medications.  Now I can 
tell them categorically that there is….if they have to continue prescribing generic medications for you, 
they need to accept that they are different, they’re produced in a different way.” (3) 
Generic prescribing is encouraged internationally and England has the highest rate in the world, with 
many patients likely to experience an imposed switch to generic medicines or even a therapeutic 
switch[48]. Patients may be unhappy with such switches, yet studies suggest that few challenge 
them[49,50]. Attitudes to generic medicines are potentially influenced by personal experiences and 
education and while patients may have misconceptions about generics[51], differing excipients 
contribute to variations in adverse effect profiles.  
Two participants considered that their lives were controlled by their need for medicines. Many others 
feared varying their doctor’s instructions, stating that medicines use was not in their control and that 
they were powerless to change it.   
“I’m in control to the extent that I have to be a slave to them… I’d be afraid to sort of do without 
them.” (1) 
“your life revolves around tablets, everything else has to fit around them” (15) 
This is similar to previous perceptions that for some patients medicines represent a “treadmill” which 
controls their lives[10]. While some patients want more involvement in making decisions regarding 
medicines, this is not universal[52,53]. However empowerment through greater understanding may 
enable patients to gain the desired degree of control over their medicines use which some seem to 
lack.     
Strengths and Limitations  
The study involved patients purposively selected from a large sample of all ages who agreed to 
participate, although willing participants may have wished to raise issues. Selection from a large 
sample ensured a wide range of drug and formulation use, whereas most previous work has focused 
on specific conditions or groups of medicines. Interviews were conducted in patients’ own homes, 
thus did not exclude the housebound or those with disabilities, and allowed individuals to fully 
describe their experiences. The number interviewed was small, but two authors were involved in 
analysis and agreed that saturation of themes was reached. The study’s origin in a School of Pharmacy 
may have contributed to positive views being expressed of pharmacists and their services and staff. 
General Discussion 
The study findings lend weight to the argument that managing chronic disease creates a burden for 
patients[1,9,30], in this case, coping with polypharmacy. They are in line with other published studies 
indicating that patients have both positive and negative views towards long-term medicines and that 
coping with medicines is one potentially burdensome aspect of medical treatment[9,30]. The themes 
emerging from the data relate well to those from such studies. Key differences are also evident, 
however, as a result of specifically seeking issues in the interviews about the impact of medicines use 
on day-to-day activities, feelings of control over medicines use and time spent in developing and 
keeping to routines.  
The positive views expressed throughout, for example, concerning good relationships with health 
professionals, clear benefits of the medicines themselves and ease of keeping to routine are all likely 
to impact positively on how patients view the impact of their medicines on overall quality of life. On 
the other hand, negative views relating to adverse effects, the extensive commitment to managing 
medicines on a day-to-day basis, lack of control over their use and impact on social life are likely to 
have negative effects on peoples’ day-to-day lives, including quality of life. While clearly of lesser 
impact than conditions for which medicines are used, it is increasingly important to be aware of how 
medicines can and do affect individuals and to be able to measure these impacts. 
These findings offer salutary lessons for practitioners, both those who prescribe ever increasing 
numbers of medicines and those purporting to help patients cope with their medicines burden. The 
tendency to prescribe too quickly, failure to explore or take account of patients’ views or to give 
credence to their concerns and to provide the sort of information they want and need to minimise the 
disruption that medicines can have on everyday life must be addressed if we are genuinely 
considering the patient perspective. As polypharmacy increases, increasing effort is needed by all 
health professionals to ensure that the burden of medicines is not too great for any individual to cope 
with. 
Conclusion 
Our study shows the multiplicity and complexity of issues surrounding long-term medicines use 
which impact on day-to-day lives for patients of all ages with long-term conditions. While most 
patients adapt to long-term medicines use, others did so at some cost to their quality of life.  
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Box 1 Topic guide for interviews 
 
Can you tell me about or show me your 
medicines? 
 
How do you actually get your medicines? 
How do you use your medicines? How do your medicines fit in with your life? 
 
How important do you feel your medicines are to 
you? 
 
How you know if your medicines are OK for 
you? 
 
Is there anything you don’t like about your 
medicines? 
 
Do you have any worries about your medicines? 
 
Do you feel you know enough about your 
medicines? 
 
Would you change anything about your 
medicines if you could? 
 
 
